1. Home
  2. ISOU vs LXRX Comparison

ISOU vs LXRX Comparison

Compare ISOU & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISOU
  • LXRX
  • Stock Information
  • Founded
  • ISOU 2016
  • LXRX 1995
  • Country
  • ISOU Canada
  • LXRX United States
  • Employees
  • ISOU N/A
  • LXRX N/A
  • Industry
  • ISOU
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISOU
  • LXRX Health Care
  • Exchange
  • ISOU Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • ISOU 357.6M
  • LXRX 388.6M
  • IPO Year
  • ISOU N/A
  • LXRX 2000
  • Fundamental
  • Price
  • ISOU $7.61
  • LXRX $1.18
  • Analyst Decision
  • ISOU
  • LXRX Buy
  • Analyst Count
  • ISOU 0
  • LXRX 5
  • Target Price
  • ISOU N/A
  • LXRX $3.23
  • AVG Volume (30 Days)
  • ISOU 51.9K
  • LXRX 2.9M
  • Earning Date
  • ISOU 05-12-2025
  • LXRX 08-06-2025
  • Dividend Yield
  • ISOU N/A
  • LXRX N/A
  • EPS Growth
  • ISOU N/A
  • LXRX N/A
  • EPS
  • ISOU N/A
  • LXRX N/A
  • Revenue
  • ISOU N/A
  • LXRX $58,432,000.00
  • Revenue This Year
  • ISOU N/A
  • LXRX N/A
  • Revenue Next Year
  • ISOU N/A
  • LXRX N/A
  • P/E Ratio
  • ISOU N/A
  • LXRX N/A
  • Revenue Growth
  • ISOU N/A
  • LXRX 1504.83
  • 52 Week Low
  • ISOU $5.72
  • LXRX $0.28
  • 52 Week High
  • ISOU $8.64
  • LXRX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • ISOU N/A
  • LXRX 57.34
  • Support Level
  • ISOU N/A
  • LXRX $1.02
  • Resistance Level
  • ISOU N/A
  • LXRX $1.27
  • Average True Range (ATR)
  • ISOU 0.00
  • LXRX 0.09
  • MACD
  • ISOU 0.00
  • LXRX -0.01
  • Stochastic Oscillator
  • ISOU 0.00
  • LXRX 59.26

About ISOU IsoEnergy Ltd. Common Shares

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: